Litcius/Paper detail

Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients

Habib Ghaznavi, Zahra Mohammadghasemipour, Milad Shirvaliloo, Mohammad Kazem Momeni, Maliheh Metanat, Farzaneh Gorgani, Fatemeh Abedipour, Mahdi Mohammadi, Majid Sartipi, Ali Reza Salimi Khorashad, Omolbanin Shahraki, Mohadese Ataee, Roghayeh Sheervalilou, Saman Sargazi

2022Inflammopharmacology19 citationsDOIOpen Access PDF

Topics & Concepts

CelecoxibMedicineInternal medicineAnalysis of varianceWhite blood cellCyclooxygenaseAdjuvant therapyDiseaseClinical trialGastroenterologyImmunologyCancerEnzymeBiologyBiochemistryInflammatory mediators and NSAID effectsCOVID-19 Clinical Research StudiesAntiplatelet Therapy and Cardiovascular Diseases
Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients | Litcius